<?xml version="1.0" encoding="UTF-8"?>
<p id="Par10">Arbidol is a non-nucleoside antiviral drug developed by the research center for pharmaceutical chemistry of the Soviet Union. Arbidol exerts an antiviral effect by inhibiting the fusion of the viral lipid membrane with the host cell to block the replication of the virus [
 <xref ref-type="bibr" rid="CR56">56</xref>, 
 <xref ref-type="bibr" rid="CR57">57</xref>]. It is active against many enveloped and non-enveloped viruses and has an interferon-inducing effect [
 <xref ref-type="bibr" rid="CR58">58</xref>]. It has been found that 10–30 μmol of arbidol could effectively inhibit SARS-CoV-2 proliferation by 60 times compared with a drug-untreated control group and significantly inhibit the pathological effects of viruses in vitro [
 <xref ref-type="bibr" rid="CR54">54</xref>, 
 <xref ref-type="bibr" rid="CR59">59</xref>].
</p>
